Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Increases By 485.4%

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 116,151 shares, an increase of 485.4% from the May 31st total of 19,840 shares. Based on an average daily volume of 284,099 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Siemens Healthineers Stock Down 0.5%

Shares of SMMNY traded down $0.10 during mid-day trading on Friday, hitting $19.43. The company’s stock had a trading volume of 241,836 shares, compared to its average volume of 169,194. Siemens Healthineers has a one year low of $19.32 and a one year high of $28.92. The stock’s 50-day moving average is $20.29 and its two-hundred day moving average is $22.91.

Siemens Healthineers (OTCMKTS:SMMNY) last announced its earnings results on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The company had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.